当前位置:首页 / VMAT联合同期化疗治疗中晚期宫颈癌临床研究▲
论著 | 更新时间:2017-06-28
|
VMAT联合同期化疗治疗中晚期宫颈癌临床研究▲
The clinical study of VMAT combined with concurrent chemotherapy in advanced cervical cancer

内科 201712卷03期 页码:309-311+328

作者机构:广东省梅州市人民医院&中山大学附属梅州医院放疗科,梅州市514000

基金信息:▲基金项目:梅州市科委立项科研项目(2015B013)

DOI:DOI:10.16121/j.cnki.cn451347/r.2017.03.04

  • 中文简介
  • 英文简介
  • 参考文献
【摘要】目的研究容积旋转调强(VMAT)联合同期化疗治疗中晚期宫颈癌的临床疗效。方法选取中晚期宫颈癌患者72例作为研究对象,采用抽签法随机分为观察组和对照组,每组36例。观察组患者给予VMAT联合同期化疗,对照组患者给予适形强调放疗(IMRT)联合同期化疗。比较两组患者的近期治疗效果、治疗期间和治疗后毒性反应;随访1年,比较两组患者无瘤生存率、远处转移率及总生存率。结果两组患者近期疗效比较差异无统计学意义(P>0.05)。观察组患者骨盆骨髓(PBM)、直肠及小肠外照剂量均显著低于对照组(P<0.05),靶区剂量均匀性指数(HI)显著优于对照组(P<0.05)。观察组患者不良反应严重程度显著低于对照组(P<0.05)。两组患者1年无瘤生存率、总生存率、远处转移率比较差异无统计学意义(P>0.05)。结论VMAT联合同期化疗治疗中晚期宫颈癌患者近期疗效与IMRT治疗方案相当,但安全性更高,可能有助于改善患者的远期治疗效果及预后。
【Abstract】ObjectiveTo study the clinical efficacy of volume rotation intensity modulated (VMAT) combined with concurrent chemotherapy in the treatment of advanced cervical cancer. MethodsA total of 72 patients with advanced cervical cancer were randomly divided into two groups, with 36 cases in each group. The observation group was treated with VMAT combined with concurrent chemotherapy, while the control group received conformal radiotherapy (IMRT) combined with concurrent chemotherapy. The shortterm therapeutic effects, toxic and side effects during the treatment period and after treatment were compared between two groups; followed up for 1 year, the tumor free survival rate, distant metastasis rate and overall survival rate were compared between two groups. ResultsThere was no significant difference in shortterm therapeutic effects between the two groups (P>0.05). The pelvic bone marrow (PBM), rectum and small intestinal external dose in the observation group were significantly lower than those in the control group(P<0.05), the uniformity index (HI) of target area dose in the observation group was significantly better than that in the control group(P<0.05). The severity of adverse reactions in the observation group were significantly lighter than that in the control group(P<0.05).There were no significant difference in 1year diseasefree survival rate, distant metastasis rate and overall survival rate between two groups (P>0.05). ConclusionsVMAT combined with concurrent chemotherapy has the same efficacy as IMRT program in the treatment of advanced cervical cancer, but it more safety, and can improve longterm prognosis.

2820

浏览量

1802

下载量

0

CSCD

工具集